Herbert Kim Lyerly (Kim Lyerly, Herbert K Lyerly, H Kim Lyerly)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 37

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancers

Cancer gene therapy

Journal for immunotherapy of cancer

Duke University School of Medicine

University of California Riverside (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Duke University School of Medicine Jul 01 1990

United States

Professor :: Surgery

Education History

University of California Riverside Sep 01 1976 - Jun 30 1980

United States

BSC

Publications

Timothy N Trotter, Andrea Wilson, Jason McBane, Carina E Dagotto, Xiao-Yi Yang, Jun-Ping Wei, Gangjun Lei, Hannah L Thrash, Joshua C Snyder, Herbert Kim Lyerly, Zachary Conrad Hartman
Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent "NoGlow" Mice. Cancer research communications 4 (4) (2024)
Surya Pandey, Meghan E Cholak, Rishita Yadali, Jeffrey A Sosman, Marie-Pier Tetreault, Deyu Fang, Seth M Pollack, Sacha Gnjatic, Rebecca C Obeng, Herbert Kim Lyerly, Adam M Sonabend, José A Guevara-Patiño, Lisa H Butterfield, Bin Zhang, Holden Terry Maecker, I Caroline Le Poole
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond. Cancers 16 (3) (2024)
Timothy N Trotter, Andrea Wilson, Jason McBane, Carina E Dagotto, Xiao-Yi Yang, Jun-Ping Wei, Gangjun Lei, Hannah L Thrash, Joshua C Snyder, Herbert Kim Lyerly, Zachary Conrad Hartman
Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent "NoGlow" Mice. Cancer research communications 4 (4) (2024)
Joshua D Ginzel, Henry Chapman, Joelle E Sills, Edwin J Allen, Lawrence S Barak, Robert D Cardiff, Alexander D Borowsky, Herbert Kim Lyerly, Bruce W Rogers, Joshua C Snyder
Nonlinear progression across the occult transition establishes cancer lethality. bioRxiv : the preprint server for biology (2024)
Surya Pandey, Meghan E Cholak, Rishita Yadali, Jeffrey A Sosman, Marie-Pier Tetreault, Deyu Fang, Seth M Pollack, Sacha Gnjatic, Rebecca C Obeng, Herbert Kim Lyerly, Adam M Sonabend, José A Guevara-Patiño, Lisa H Butterfield, Bin Zhang, Holden Terry Maecker, I Caroline Le Poole
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond. Cancers 16 (3) (2024)
Joshua D Ginzel, Henry Chapman, Joelle E Sills, Edwin J Allen, Lawrence S Barak, Robert D Cardiff, Alexander D Borowsky, Herbert Kim Lyerly, Bruce W Rogers, Joshua C Snyder
Nonlinear progression across the occult transition establishes cancer lethality. bioRxiv : the preprint server for biology (2024)
Surya Pandey, Meghan E Cholak, Rishita Yadali, Jeffrey A Sosman, Marie-Pier Tetreault, Deyu Fang, Seth M Pollack, Sacha Gnjatic, Rebecca C Obeng, Herbert Kim Lyerly, Adam M Sonabend, José A Guevara-Patiño, Lisa H Butterfield, Bin Zhang, Holden Terry Maecker, I Caroline Le Poole
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond. Cancers 16 (3) (2024)
Surya Pandey, Meghan E Cholak, Rishita Yadali, Jeffrey A Sosman, Marie-Pier Tetreault, Deyu Fang, Seth M Pollack, Sacha Gnjatic, Rebecca C Obeng, Herbert Kim Lyerly, Adam M Sonabend, José A Guevara-Patiño, Lisa H Butterfield, Bin Zhang, Holden Terry Maecker, I Caroline Le Poole
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond. Cancers 16 (3) (2024)
Herbert Kim Lyerly
Self-replicating messenger RNA based cancer immunotherapy. Cancer gene therapy (2023)
Michael A Morse, Erika J Crosby, Jeremy Force, Takuya Osada, Amy C Hobeika, Zachary Conrad Hartman, Peter Berglund, Jonathan Smith, Herbert Kim Lyerly
Clinical trials of self-replicating RNA-based cancer vaccines. Cancer gene therapy (2023)
Michael A Morse, Erika J Crosby, Jeremy Force, Takuya Osada, Amy C Hobeika, Zachary Conrad Hartman, Peter Berglund, Jonathan Smith, Herbert Kim Lyerly
Clinical trials of self-replicating RNA-based cancer vaccines. Cancer gene therapy (2023)
Herbert Kim Lyerly
Self-replicating messenger RNA based cancer immunotherapy. Cancer gene therapy (2023)
Erika J Crosby, Zachary Conrad Hartman, Herbert Kim Lyerly
Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Michael A Morse, Erika J Crosby, Jeremy Force, Takuya Osada, Amy C Hobeika, Zachary Conrad Hartman, Peter Berglund, Jonathan Smith, Herbert Kim Lyerly
Clinical trials of self-replicating RNA-based cancer vaccines. Cancer gene therapy (2023)
Brooke E Wilson, Richard Sullivan, Richard Peto, Abubakar Bello, Christopher M Booth, Gustavo Werutsky, Cary Adams, Agnes Saint-Raymond, Thomas R Fleming, Herbert Kim Lyerly, Julie R Gralow
Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting. JCO global oncology 9 (2023)
Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua D Ginzel, Zachary Hartman, Jeffrey I Everitt, Philip F Hughes, Timothy Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity. Cancers 14 (23) (2022)
Bin-Jin Hwang, Li-Chung Tsao, Chaitanya R Acharya, Timothy Trotter, Pankaj Agarwal, Junping Wei, Tao Wang, Xiao-Yi Yang, Gangjun Lei, Takuya Osada, Herbert Kim Lyerly, Michael A Morse, Zachary Conrad Hartman
Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression. Journal for immunotherapy of cancer 10 (3) (2022)
Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua D Ginzel, Zachary Hartman, Jeffrey I Everitt, Philip F Hughes, Timothy Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity. Cancers 14 (23) (2022)
Clare A Rebbeck, Jian Xian, Susanne Bornelöv, Joseph Geradts, Amy Hobeika, Heather Geiger, Jose Franco Alvarez, Elena Rozhkova, Ashley Nicholls, Nicolas Robine, Herbert Kim Lyerly, Gregory James Hannon
Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma. Nature communications 13 (1) (2022)
Kensuke Kaneko, Chaitanya R Acharya, Hiroshi Nagata, Xiao Yang, Zachary Conrad Hartman, Amy Hobeika, Philip F Hughes, Timothy A J Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers. Journal for immunotherapy of cancer 10 (9) (2022)
Shinya Abe, Hiroshi Nagata, Erika J Crosby, Yoshiyuki Inoue, Kensuke Kaneko, Cong-Xiao Liu, Xiao Yang, Tao Wang, Chaitanya R Acharya, Pankaj Agarwal, Joshua Snyder, William Gwin, Michael A Morse, Pei Zhong, Herbert Kim Lyerly, Takuya Osada
Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity. Journal for immunotherapy of cancer 10 (1) (2022)
Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua D Ginzel, Zachary Hartman, Jeffrey I Everitt, Philip F Hughes, Timothy Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity. Cancers 14 (23) (2022)
Melinda L Telli, Hiroshi Nagata, Irene Wapnir, Chaitanya R Acharya, Kaitlin Zablotsky, Bernard A Fox, Carlo B Bifulco, Shawn M Jensen, Carmen Ballesteros-Merino, Mai Hope Le, Robert H Pierce, Erica Browning, Reneta Hermiz, Lauren Svenson, Donna Bannavong, Kim Jaffe, Jendy Sell, Kellie Malloy Foerter, David A Canton, Christopher G Twitty, Takuya Osada, Herbert Kim Lyerly, Erika J Crosby
Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Joshua D Ginzel, Chaitanya R Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G Boone, Lauren K Rochelle, Wendy L Roberts, Jeffrey I Everitt, Zachary Conrad Hartman, Erika J Crosby, Lawrence S Barak, Marc G Caron, Jane Q Chen, Neil E Hubbard, Robert D Cardiff, Alexander D Borowsky, Herbert Kim Lyerly, Joshua C Snyder
HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. Molecular cancer research : MCR 19 (10) (2021)
Daniel D Von Hoff, Gary M Clark, Charles A Coltman, Mary L Disis, S G Eckhardt, Lee M Ellis, Margaret Foti, Elizabeth Garrett-Mayer, Mithat Gönen, Manuel Hidalgo, Susan G Hilsenbeck, John H Littlefield, Patricia M LoRusso, Herbert Kim Lyerly, Neal J Meropol, Jyoti D Patel, Steven Piantadosi, Dean A Post, Meredith M Regan, Yu Shyr, Margaret A Tempero, Joel E Tepper, Jamie Von Roenn, Louis M Weiner, Donn C Young, Nu V Vu
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Erika J Crosby, Amy C Hobeika, Donna Niedzwiecki, Christel Rushing, David Hsu, Peter Berglund, Jonathan Smith, Takuya Osada, William R Gwin Iii, Zachary Conrad Hartman, Michael A Morse, Herbert Kim Lyerly
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Journal for immunotherapy of cancer 8 (2) (2021)
Takuya Osada, Erika J Crosby, Kensuke Kaneko, Joshua C Snyder, Joshua D Ginzel, Chaitanya R Acharya, Xiao-Yi Yang, Thomas J Polascik, Ivan Spasojevic, Rendon C Nelson, Amy Hobeika, Zachary Conrad Hartman, Leonard M Neckers, André Rogatko, Philip F Hughes, Jiaoti Huang, Michael A Morse, Timothy Haystead, Herbert Kim Lyerly
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study. Molecular cancer therapeutics (2021)
Sung Han Rhew, Julia Kravchenko, Herbert Kim Lyerly
Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina. PloS one 16 (7) (2021)
Navid Hafez, Hope S Rugo, Margaret A Tempero, Elizabeth Fox, Gregory H Reaman, Herbert Kim Lyerly, Desiree Walker, Patricia M LoRusso
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)
Kensuke Kaneko, Takuya Osada, Michael A Morse, William R Gwin, Joshua D Ginzel, Joshua C Snyder, Xiao-Yi Yang, Cong-Xiao Liu, Marcio Augusto Diniz, Khaldon Bodoor, Philip F Hughes, Timothy Aj Haystead, Herbert Kim Lyerly
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors. Communications biology 3 (1) (2020)
Timothy N Trotter, Casey W Shuptrine, Li-Chung Tsao, Robert D Marek, Chaitanya R Acharya, Jun-Ping Wei, Xiao-Yi Yang, Gangjun Lei, Tao Wang, Herbert Kim Lyerly, Zachary Conrad Hartman
IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils. Cancer research 80 (15) (2020)
Erika J Crosby, Chaitanya R Acharya, Anthony-Fayez Haddad, Christopher A Rabiola, Gangjun Lei, Jun-Ping Wei, Xiao-Yi Yang, Tao Wang, Cong-Xiao Liu, Kay-Uwe Wagner, William J Muller, Lewis A Chodosh, Gloria Broadwater, Terry Hyslop, Jonathan H Shepherd, Daniel P Hollern, Xiaping He, Charles M Perou, Shengjie Chai, Benjamin K Ashby, Benjamin G Vincent, Joshua C Snyder, Jeremy Force, Michael A Morse, Herbert Kim Lyerly, Zachary Conrad Hartman
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)
Erika J Crosby, William R Gwin, Kimberly Blackwell, P Kelly Marcom, Serena Chang, Holden T Maecker, Gloria Broadwater, Terry Hyslop, Sungjin Kim, Andre Rogatko, Veronica Lubkov, Joshua C Snyder, Takuya Osada, Amy C Hobeika, Michael A Morse, Herbert Kim Lyerly, Zachary Conrad Hartman
Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (9) (2019)
Michael Cecchini, Eric H Rubin, Gideon M Blumenthal, Kassa Ayalew, Howard A Burris, Michele Russell-Einhorn, Hildy Dillon, Herbert Kim Lyerly, Gregory H Reaman, Scott Boerner, Patricia M LoRusso
Challenges with Novel Clinical Trial Designs: Master Protocols. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (7) (2019)
Guoliang Qiao, Xiaoli Wang, Lei Zhou, Xinna Zhou, Yuguang Song, Shuo Wang, Lei Zhao, Michael A Morse, Amy Hobeika, Jin Song, Xin Yi, Xuefeng Xia, Jun Ren, Herbert Kim Lyerly
Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (5) (2018)
Takuya Osada, Zachary C Hartman, Junping Wei, Gangjun Lei, Amy C Hobeika, William R Gwin, Marcio A Diniz, Neil Spector, Timothy M Clay, Wei Chen, Michael A Morse, Herbert Kim Lyerly
Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers. Breast cancer research : BCR 20 (1) (2018)
Herbert Kim Lyerly, Takuya Osada, Zachary Conrad Hartman
Right Time and Place for IL12: Targeted Delivery Stimulates Immune Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (1) (2018)

Herbert Kim Lyerly.css-eqlu8i{font-size:small;padding-left:4px;} (Kim Lyerly, Herbert K Lyerly, H Kim Lyerly)

Publication Activity (10 Years)

Top Topics

Top Venues

Herbert Kim Lyerly (Kim Lyerly, Herbert K Lyerly, H Kim Lyerly)